Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07453797

A Prospective Study Assessing ActivSight Imaging for Intraoperative Perfusion Evaluation in Left-Sided Colectomy

The goal of this clinical trial is to evaluate and compare the clinical utility of Indocyanine Green (ICG) fluorescence angiography and Laser Speckle

Contrast Imaging (LSCI) in assessing intraoperative tissue perfusion at the anastomotic site during colorectal resection in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main question[s] it aims to answer [is/are]:

What is the clinical utility of Indocyanine Green (ICG) fluorescence angiography compared to Laser Speckle Contrast Imaging (LSCI) in assessing intraoperative tissue perfusion at the anastomotic site during colorectal resection?

Participants will undergo a laparoscopic/robotic (where an extracorporeal anastomosis formed)/open colectomy with ligation of the inferior mesenteric artery and a planned anastomosis of 5cm to 15 cm from the anal verge where both ICG and LSCI modalities will be applied to all subjects.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This is a single-arm, prospective, non-randomized, within-patient crossover study designed to evaluate the effectiveness of Laser Speckle Contrast Imaging (LSCI) using ActivSight™ as an advanced intraoperative visualization tool for assessing tissue perfusion in left-sided colectomies. The standard of care-Indocyanine Green (ICG) fluorescence angiography-will be used concurrently to compare perfusion assessment capabilities between the two imaging modalities. The study will also explore the potential of LSCI in reducing the incidence of anastomotic leak (AL) and related postoperative complications.

Participants will undergo left-sided colorectal resection (high or low) with planned anastomosis 5 - 15cm from the anal verge using a circular stapler. The procedure may be performed using either a laparoscopic, open or robotic approach with standard surgical equipment based on the surgeon's standard technique.

  • High anterior resection is defined as resection and anastomosis above the peritoneal reflection.
  • Low anterior resection refers to resection and anastomosis below the peritoneal reflection.

The specific operative technique, including the method of stapled will be at the discretion of the operating surgeon. The level of colonic transection, formation of an anastomosis, and any defunctioning stoma will be performed in accordance with the surgeon's standard clinical practice

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is scheduled for laparoscopic/robotic (where an extracorporeal anastomosis formed)/open colectomy with ligation of the inferior mesenteric artery and a planned anastomosis of 5cm to 15 cm from the anal verge using a circular stapler only
  • A negative pregnancy test for women of childbearing potential prior to surgery
  • Participants who are able and willing to complete required study procedures
  • Participants who are able and willing to provide a signed and dated ICF

Exclusion criteria

  • Subject has a previous history of adverse reaction or known allergy to ICG, iodine or iodine dyes
  • Subject who receives hand sewn anastomosis
  • Subject has any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the study procedure
  • Subject has a previous history of radiation therapy
  • Subject that has Hinchey 3 and 4 diverticulitis
  • Subject is a pregnant or lactating female

Treatment and study plan

ActivSight™ Intraoperative Imaging System

Device

ActivSight™ Intraoperative Imaging System which consists of an infrared-sensitive monochrome imaging sensor adapter and a customized light source with 1 or more coherent laser sources. In LSCI mode, proprietary algorithms detect perfusion using motion in real time, projecting a false color overlay on the standard white light laparoscopic image. This Food and Drug Administration-approved technology has the capacity for both ICG NIRF and LSCI.

Primary outcomes

  1. White Light Imaging

    Time frame: during surgery

    Determine optimal proximal bowel transection site using white light imaging or naked eye, marking with clip, bovie, pen, etc.

  2. ICG Uptake

    Time frame: during surgery

    Determine the optimal proximal bowel transection site using at initial uptake of ICG prior to division of bowel and determine diffusion of ICG at 30 seconds, 60 seconds and 90 seconds after initial uptake.

  3. LSCI-based Perfusion

    Time frame: during surgery

    Determine the optimal proximal bowel transection site using LSCI-based perfusion imaging prior to division of bowel.

Secondary outcomes

  1. Tissue Perfusion

    Time frame: during surgery

    Assess and compare tissue perfusion prior to anastomosis being completed (e.g. anvil has been placed) and post-anastomosis stages using LSCI and ICG.

  2. Diversion

    Time frame: during surgery

    Decision to divert or not to divert

  3. Surgical Decision Making

    Time frame: during surgery

    Impact on intraoperative surgical decision-making, including changes in transection site or operative plan.

  4. Anastomotic Leak Rate

    Time frame: from surgery to end of follow up period/30 days post surgery

    Determine <30-day postoperative anastomotic leak (AL) rate, associated complications, morbidity, mortality and overall complication rates using the Clavien-Dindo classification system.

Sponsors and collaborators

Lead sponsor

Activ Surgical

Industry

Registry information

Official study title

A Single Arm, Prospective, Open Label, Multicenter Study Assessing Efficacy and Utility of the Visualization of Intraoperative Speckle Imaging for Real-Time Assessment Of PerfusioN in Left Sided Colectomy With ActivSight

Acronym: VISION

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Mar 6, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.